Daito Pharmaceutical ,Ltd. Total Current Liabilities

Daito Pharmaceutical ,Ltd. (4577.T) currently reports a total current liabilities of $14B as of May 2026. That compares with $17B in the prior-year period — down 17.9% year over year. Use the charts on this page to explore Daito Pharmaceutical ,Ltd.'s total current liabilities history and peer comparisons.

Daito Pharmaceutical ,Ltd.'s total current liabilities decreased from $17B to $14B — a 17.9% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Daito Pharmaceutical ,Ltd. reported $14B in total current liabilities as of May 2026. That compares with $17B in the prior-year period — down 17.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Daito Pharmaceutical ,Ltd., and consider following 4577.T for alerts when major investors trade the stock.